Evidence map›Paper›PMID 36499490›Full record

ArticleInternational journal of molecular sciences2022

Promitotic Action of

Sara Ceccacci, Kévin Roger, Ines Metatla, Cerina Chhuon, Khaled Tighanimine, Stefano Fumagalli, Adriana De Lucia, Iwona Pranke, Corinne Cordier, Maria Chiara Monti and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Sara CeccacciDepartment of Pharmacy, University of Salerno, 84084 Fisciano, Italy.ORCID 0000-0002-7918-0598
Kévin RogerProteomics Platform Necker, Université Paris Cité-Structure Fédérative de Recherche Necker, INSERM US24/CNRS UAR3633, 75015 Paris, France.ORCID 0000-0003-1353-3415
Ines MetatlaProteomics Platform Necker, Université Paris Cité-Structure Fédérative de Recherche Necker, INSERM US24/CNRS UAR3633, 75015 Paris, France.
Cerina ChhuonProteomics Platform Necker, Université Paris Cité-Structure Fédérative de Recherche Necker, INSERM US24/CNRS UAR3633, 75015 Paris, France.
Khaled TighanimineInstitut Necker Enfants Malades, INSERM U1151, 75015 Paris, France.
Stefano FumagalliInstitut Necker Enfants Malades, INSERM U1151, 75015 Paris, France.ORCID 0000-0001-5832-8680
Adriana De LuciaArterra Bioscience SpA, 80142 Naples, Italy.
Iwona PrankeInstitut Necker Enfants Malades, INSERM U1151, 75015 Paris, France.
Corinne CordierCytometry Platform, Structure Fédérative de Recherche Necker, INSERM US24-CNRS UAR3633, 75015 Paris, France.
Maria Chiara MontiDepartment of Pharmacy, University of Salerno, 84084 Fisciano, Italy.ORCID 0000-0002-1337-2909
Ida Chiara GuerreraProteomics Platform Necker, Université Paris Cité-Structure Fédérative de Recherche Necker, INSERM US24/CNRS UAR3633, 75015 Paris, France.ORCID 0000-0002-4832-6793
Centre National de la Recherche Scientifique · FRInserm · FRUniversity of Salerno · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulation of senescent dermal fibroblasts drives skin aging. The reactivation of proliferation is one strategy to modulate cell senescence. Recently, we reported the exact chemical composition of the hydrophilic extract of

Indexed as

Oenothera biennisProteomicsCells, CulturedCellular SenescenceFibroblastsHumansSkindiaPASEFfibroblastsmass spectrometrymitosisOenothera biennis hydrophilic extractproteomicssenescenceskin aging

Identifiers

PMID36499490
PMCPMC9735661
OpenAlexW4311101812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.